These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4055543)

  • 61. Clinical trial of cefuroxime axetil in children.
    Carson JW; Watters K; Taylor MR; Keane CT
    J Antimicrob Chemother; 1987 Jan; 19(1):109-12. PubMed ID: 3494006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical studies on cefuroxime axetil in acute mastitis].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J
    Jpn J Antibiot; 1987 Feb; 40(2):340-8. PubMed ID: 3599383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL; Whalen E; Echols RM; Heyd A
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications.
    Gold B; Rodriguez WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):82-100. PubMed ID: 6344037
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
    Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
    Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Short-course antibiotic therapy for infections with a single causative pathogen.
    Adam D
    J Int Med Res; 2000; 28 Suppl 1():13A-24A. PubMed ID: 11092226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
    Gooch WM; Swenson E; Higbee MD; Cocchetto DM; Evans EC
    Clin Ther; 1987; 9(6):670-7. PubMed ID: 3125976
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
    Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An assessment of the clinical efficacy in general practice of cefuroxime axetil when used in the management of unidentified infections of the lower respiratory tract.
    Wight LJ; Vandenburg MJ; Griffiths GK; Gudgeon AC; Kelsey M
    Br J Clin Pract; 1987 Nov; 41(11):991-4. PubMed ID: 3504320
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical study of cefuroxime in the treatment of lower respiratory tract infections.
    Samanta TC; Bax RP; Pearson RM; Havard CW; Brumfitt W; Hamilton-Miller JM
    Curr Med Res Opin; 1980; 6(7):466-71. PubMed ID: 7363646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.
    Rudnicka L; Szymańska E; Walecka I; Słowińska M
    Dermatology; 2000; 200(2):129-31. PubMed ID: 10773701
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
    Bedenic B; Topic M; Budimir A; Bubonja M
    Chemotherapy; 2006; 52(6):293-7. PubMed ID: 17008781
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cefuroxime axetil].
    Matsumoto F; Oizumi K
    Jpn J Antibiot; 1988 Sep; 41(9):1181-93. PubMed ID: 3071614
    [No Abstract]   [Full Text] [Related]  

  • 74. A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Höffken G; Barth J; Rubinstein E; Beckmann H;
    Infection; 2007 Dec; 35(6):414-20. PubMed ID: 18034211
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.
    Walstad RA; Nilsen OG; Berg KJ
    Eur J Clin Pharmacol; 1983; 24(3):391-8. PubMed ID: 6861853
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
    Ginsburg CM; McCracken GH; Petruska M; Olson K
    Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Definition of urinary tract infection and assessment of efficacy in drug trials--a laboratory perspective.
    Slack RC
    Infection; 1992; 20 Suppl 3():S155-6. PubMed ID: 1490741
    [No Abstract]   [Full Text] [Related]  

  • 79. A large scale, general practice based investigation into the clinical efficacy and tolerability of cefuroxime axetil in women with uncomplicated urinary tract infection.
    Bulpitt D; Potter CE; Jaderberg M
    Curr Med Res Opin; 1991; 12(5):318-24. PubMed ID: 2004544
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and pharmacokinetic comparison of cefuroxime sodium and cefuroxime lysine in the treatment of lower respiratory tract infections.
    Havard CW; Fernando A; Bannister B; Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1981 Nov; 8(5):401-8. PubMed ID: 7319981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.